When Did The Covid-19 Vaccine Come Out

spot_img
- Advertisement -

Early Authorizations In China And Russia

How did we get Covid-19 vaccines so quickly

On 24 June 2020, China approved the CanSino vaccine for limited use in the military and two inactivated virus vaccines for emergency use in high-risk occupations. On 11 August 2020, Russia announced the approval of its Sputnik V vaccine for emergency use, though one month later only small amounts of the vaccine had been distributed for use outside of the phase 3 trial. In September, the United Arab Emirates approved emergency use of Sinopharm‘s vaccine for healthcare workers, followed by similar emergency use approval from Bahrain in November.

What Might The Timeline For The Rollout Of The Vaccine Look Like

Its still too early to know when, exactly, the Pfizer vaccine will be widely available to the public, but in a recent interview with CNN, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, predicted that it could be as soon as April 2021. So while were getting close, were not quite to the finish line yet. Lyke says that we should have results of Pfizers second interim analysis as well as two months of safety data meaning information on how the participants tolerated the vaccine within a few months. From there, the data will be sent to the FDA, though, as Lyke points out, additional safety data will continue to be collected from participants over the next two years.;;

Is The Coronavirus Vaccine Made From Fetal Cell Lines

By Matt Hadro

Washington, D.C. Newsroom, Jul 28, 2020 / 15:00 pm

As coronavirus vaccine prototypes move closer to testing and approval, some Catholics are debating the ethical sources behind a leading vaccine candidate.

On Monday, President Donald Trump announced that the vaccine mRNA-1273, co-designed by the biotechnology company Moderna and the National Institute of Allergy and Infectious Diseases , had entered phase 3 of clinical trials. The vaccine will soon be tested for safety, and to confirm that it can effectively prevent COVID-19 in two doses.

Dr. Anthony Fauci, director of NIAID and White House health advisor, said on Monday that a vaccine is “urgently” required to “control this pandemic,” but has also cautioned in recent days that, despite speedy progress, a vaccine might not be widely available until several months into 2021.

The Trump administration is funding vaccine candidates as part of “Operation Warp Speed,” making investments in vaccine candidates from Novavax, Moderna, AstraZeneca, and Janssen. It is also investing $1.95 billion with Pfizer to facilitate the delivery of 100 million doses after a vaccine is developed.

On Monday Fauci said that early testing of the Moderna vaccine indicates that it is “safe and immunogenic.”

According to CLI, two vaccine candidates are the product of unethical programs-those being developed by the University of Oxford and Astrazeneca, and by Johnson & Johnson and Janssen Res. & Devel., Inc.

More in US

Also Check: How Long Does Cvs Covid Test Results Take

Hundreds Of Vaccine Candidates Are Being Developed And Tested Simultaneously

Another advantage we, as a global community, are benefiting from in terms of vaccine development is “the power of plenty.”

“The sheer number of vaccine candidates for one specific disease is extraordinary,” explains Dr. Sostman. “It’s helping us make up for the trial-and-error process that often accompanies vaccine development.”

Of these vaccine candidates, some use different targets, some use different technology and having this level of diversity and saturation is a powerful position to be in during a pandemic.

“If one vaccine candidate isn’t effective enough, it falls out of clinical trial but a more effective one is likely right in its wake. If a vaccine has adverse effects, the clinical trial is immediately halted, but there’s likely another vaccine right behind it that may have fewer side effects,” explains Dr. Sostman. “This is a position we’ve never been in before when it comes to vaccine development.”

How Long Do Vaccine Side Effects Last

Employers can require the COVID

Typically, vaccine side effects only last a couple of days.

Typically, vaccine side effects don’t last longer than a couple of days, Mathew says. Some people may experience side effects for several days. Side effects that were related directly to the injection site, like bruising and redness, should subside relatively quickly, while whole-body side effects like fever and headache may last longer.

If you’re still having side effects a week or more after you get a vaccine — COVID-19 or otherwise — call your doctor or go to urgent care. If you feel the effects are life-threatening , seek emergency medical care right away.

Read Also: How Long Cvs Covid Test Results

Myth : We Dont Know Whats In These Vaccines

All three U.S. vaccine makers have published the ingredient lists for their vaccines, available on their websites. The CDCs website also tells you whats in the COVID-19 vaccines.

The star ingredient is the COVID-19 mRNA or DNA for the spike protein. Both vaccines also contain lipids that help deliver the mRNA into your cells and a few other common ingredients that help maintain the pH and stability of the vaccine.

Despite theories circulated on social media, none of the COVID-19 vaccines contain microchips or any form of tracking device.

What Did We Learn From The Pfizer Announcement

To start with, as the Pfizer news release notes in its headline, this is the first interim analysis: not the final results of the study. Its kind of like a first peek, saysDr. Wilbur Chen, the chief of the adult clinical studies section within theCenter for Vaccine Development and Global Health at theUniversity of Maryland School of Medicine , adding that the findings in the Pfizer announcement come a little more than halfway through the analysis of the clinical trials data. Chen and his colleagues are particularly familiar with the research: In May, theCenter for Vaccine Development became one of the four testing U.S. sites that conducted phase-one of the Pfizer Covid vaccine clinical trials, and, more recently, phase-three of the Moderna vaccine trials.;

Those pointing to the fact that this information coming from a company press release and not a peer-reviewed journal article are not wrong. Academic peer-review is a crucial step in the research process, and involves other experts in a field evaluating, improving, and validating the data and methodology of a study. The Pfizer release isnt a peer-reviewed journal article, but its also not even the complete analysis of the studys data nor does it pretend to be. Despite it being a release from the manufacturer, there have been many federal agencies and academic organizations involved in doing the study, Chen says. So I think that we can trust this early information, but it is early information.

You May Like: Why Does Everything Taste Bad To Me Suddenly

‘a Momentous Day But Huge Task Ahead’

This is a momentous day, but make no mistake the NHS faces a huge task in rolling out this vaccine.

First, there needs to be a smooth supply – and already there are reports of manufacturing problems, which means the UK is expecting less than half of the 10 million doses of the Pfizer jab it was planning for by the end of the year.

The fact it needs to be kept in ultra-cold storage and in batches of 975 units is an added complication that has meant it cannot yet be taken into care homes to vaccinate residents – the very highest priority group – or sent out to GPs to run vaccination clinics in the community.

NHS bosses hope to receive guidance from the regulator next week on how to get around this.

But these factors illustrate why the UK is still pinning its hopes on a second vaccine developed by Oxford University.

That one can be kept in fridges and so is easier to distribute, is British-made and – what is more – there is an ever-growing stockpile ready to use.

If that vaccine gets the green light from regulators, there will be a genuine hope the first few months of 2021 will see rapid progress in offering jabs to the most vulnerable people, so the UK can return to something closer to normality.

Are you receiving the Covid-19 vaccine today? Or do you have any questions? Get in touch by emailing .

Please include a contact number if you are willing to speak to a BBC journalist. You can also get in touch in the following ways:

  • WhatsApp: +44 7756 165803

Number Of Doses Per Vaccine Vial

US Nurse Who Fainted After Covid-19 Vaccine Shot Dead? | Fact Check
  • For; the Pfizer/BioNTech ;vaccine, a special technique has been developed to extract as many doses as possible from the vials. Only care workers who have been trained to use this technique are allowed to prepare the doses in this way;
  • A maximum of eleven doses may be extracted from the Moderna vaccine vial;;
  • A maximum of twelve doses may be extracted from the AstraZeneca vaccine vial.;

Detailed instructions on vaccine preparation are provided in the Implementation Guidelines for COVID-19 Vaccination .

Read Also: Did Hank Aaron Get Covid Vaccine

Grafiek Vaccinatiegraad Eerste Vaccinatie

Figure 1: Cumulative turnout for at least one COVID-19 vaccination by birth year and week, weeks 1-37, 2021.;;1-6

  • Week numbers are calendar weeks : week 1 = 4-10 January 2021, week 2 = 11-17 January 2021, etc.
  • In contrast to the other birth years, people born in 1956-1960 have primarily been vaccinated with VAX via their GP. The figures for vaccinations given by the GP are based on the vaccinations registered in CIMS. VAX was temporarily not administered from 15-23 March 2021 and from 3-5 April 2021.
  • Vaccinated persons who are not registered in the Personal Records Database are included in the numerator but not in the denominator in calculating the vaccination turnout. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
  • The term turnout is used to indicate what percentage of the population has received a specific dose in a vaccination series. The term vaccination coverage is used to indicate what percentage of the population is fully vaccinated.
  • What Dont We Know At This Point

    Pfizer may be halfway through analyzing the data from the Covid vaccine clinical trials, but theres still plenty we dont yet know, including the final efficacy rate. Its a little more than 90 percent now, but thats an estimate, Chen explains.

    There are also several other crucial pieces to the vaccine puzzle that wont be put in place until more time has passed. For example, it is not yet known how long the vaccine will protect someone against the novel coronavirus whether its a few months, a year, or more. We also wont know if it helps stop transmission among asymptomatic people, Chen says. Thats not really answered in this study, because it was not designed to do that.;

    At this stage, its also unclear whether the Pfizer Covid vaccine candidate protects against the severity of the infection, which can be mild, moderate, or severe enough to require hospitalization and cause death. But according to Chen, at the very least we do know that the vaccine can prevent mild cases of the symptomatic illness. So presumably that means that if you can prevent that, then you can prevent subsequent hospitalization and/or death, he adds.

    Don’t Miss: How Long For Cvs Covid Test Results

    What Do I Need To Know About The Delta Variant

    The Delta variant is different from previous SARS-CoV-2 variants that have made their way to the US. Its highly contagious and may cause more severe disease. It is also more likely than previous variants to be spread by vaccinated people experiencing breakthrough infections.

    Evidence presented to the CDC showed the Delta variant to be much more contagious than previous variants, with a risk of transmission similar to chickenpox. It also appears that people who are infected can spread the virus for longer periods of time.

    In addition, people who are vaccinated and then get infected can also spread the virus to others, perhaps to the same extent as those who are unvaccinated. This is also new; vaccinated people were much less likely to spread previous variants.

    Finally, international studies point to the Delta variant being more likely to cause severe disease.

    The good news is that while vaccination may be less effective at preventing infection and spread of the Delta variant, it is still highly protective against severe disease, hospitalization, and death. Get the COVID-19 vaccine if you have not already done so.

    In July 2021, the CDC advised all people vaccinated and unvaccinated to wear masks in public indoor places, in areas of the country with substantial or high transmission of the virus. Given the threat posed by the Delta variant, its reasonable for everyone to start wearing a mask in indoor public spaces, regardless of the level of virus in your area.

    Myth : The Vaccine Will Cause Infertility

    Are Covid vaccines safe and useful?

    Because the COVID-19 vaccines dont contain the live virus , they are not thought to cause an increased risk of;infertility, first or second-trimester loss, stillbirth or congenital anomalies. Additionally, there is no evidence to suggest that the vaccine is a risk to a breastfeeding baby.

    Doctors believe it is safe to get the COVID-19 vaccine if youre pregnant, and the CDC strongly encourages pregnant people to receive the COVID-19 vaccine.

    Read Also: Why Does Everything Taste Bad

    Will The Covid Vaccine Prevent Me From Infecting Others

    Increasing evidence suggests that a person who has been vaccinated is less likely to infect others.

    Two studies released in February pointed in this direction. The first study looked at viral load the amount of SARS-CoV-2 virus in a person’s nose and throat, which can be spread to others. The study found that the higher a person’s viral load, the more likely they were to spread the infection; the lower a person’s viral load, the less likely they were to spread the infection. Results from the second study suggested that people who became infected with SARS-CoV-2 after getting a COVID vaccine had a lower viral load than people who were infected but had not had a COVID vaccine. Taken together, the studies suggest that the COVID vaccine protects against both infection and transmission.

    A study published in March 2021 showed that people who received an mRNA vaccine had significantly less risk of asymptomatic infection than people who were unvaccinated. This is important because people who are infected but never go on to develop symptoms are responsible for an estimated 24% of SARS-CoV-2 transmission.

    Can The Vaccines Protect People Against The Virus Variants

    Viruses typically;mutate. A mutation is when the;genetic material;in the virus changes. Sometimes, one or more mutations can bring about a new variant of the virus.

    These variants might behave in different ways to the original virus. They may be more infectious, for example.

    Mutations happen at;different rates;in different viruses. They do not necessarily affect how well vaccines;work against the virus.

    The scientific community and regulators are closely monitoring how;SARS-CoV-2; is changing over time, and how well COVID-19 vaccines protect people against COVID-19 caused by;variants;of the virus. This information will help determine if people will need to be vaccinated against COVID-19 in the future, like they do against influenza , or if the initial;vaccination course is sufficient, as it is for measles.

    EMA has asked all the COVID-19 vaccine developers to investigate whether their vaccines can offer protection against the new variants. These include:

    • Alpha ;
    • Beta ;
    • Gamma ;
    • Delta .

    EMA has asked the developers to submit any relevant data for regulatory assessment.

    EMA has issued;guidance for;developers;planning to adapt COVID-19 vaccines to address;new virus variants. This guidance sets out the;data;developers need to provide to support the approval of the adapted vaccines in the EU.

    For details, see:

    Don’t Miss: How Many Weeks Between Covid Vaccines

    What Is The Status Of Covid

    More on:

    More than a dozen vaccines have been approved for general or emergency use in countries including China, Russia, the United Kingdom, and the United States. As of summer 2021, more than three billion doses had been administered worldwide. Several countriesincluding Bahrain, Israel, and the United Stateshave made significant progress in immunizing their citizens, while others have vaccinated only small fractions of their populations and a handful are yet to start.

    The uneven rollout of vaccines has been felt sharply in places such as India, where the spread of new variants and relaxed restrictions led to a devastating surge in June that has impeded vaccine shipments elsewhere. In recent weeks, the World Health Organization has raised the alarm about a third wave of COVID-19 cases across Africa, where just over 1 percent of the population has been fully vaccinated.

    Which Vaccines Has The Fda Approved And Authorized For Covid

    Over-25s in England invited to come forward for Covid-19 vaccination | ITV News

    In August 2021, the FDA granted full approval to the mRNA COVID-19 vaccine developed by Pfizer and BioNTech. This vaccine had received emergency use authorization in December 2020. The mRNA COVID-19 vaccine developed by Moderna also received EUA in December 2020. The Johnson & Johnson adenovirus vaccine was granted EUA by the FDA in late February 2021. Use of the Johnson & Johnson vaccine resumed on April 23, 2021, after a temporary pause.

    Recommended Reading: How Long Cvs Covid Test Results

    Who Is Working On A Covid

    At time of writing, there were well over 100 research teams worldwide;developing a COVID-19 vaccine. So far, 34 teams have advanced their vaccines to the third phase of clinical trials. Although some of these vaccines have already been approved in some countries, they still continue to be tested in clinical trials in parallel.

    Five teams stand out for conducting the most extensive clinical trials:;

    • Belgian company;;is testing its candidate vaccine, which is based on a nonreplicating viral vector, on about 576,000 people in South Africa, Belgium, the United States, Argentina, Brazil and;Colombia.
    • The US company;Moderna;is testing its RNA-based vaccine;on 79,000 people in the US, Canada, France and Japan
    • In a public-private partnership between the University of Oxford and the British company;AstraZeneca, researchers are testing their vaccine candidate on approximately 66,000 people in the US, Chile, Peru and the UK. Their vaccine is based on a similar principle to Janssen’s.
    • The Chinese company;Sinopharm;is working in various constellations with the Beijing Institute and Wuhan Institute. Taking all trial series together, they are testing an “inactivated” vaccine on around 61,000 people in Bahrain, Jordan, Egypt, Morocco, Argentina and Peru.;
    • A German company, BioNTech, is pursuing a different approach: It is focusing on RNA-based technology and testing the BioNTech-Pfizer;candidate vaccine on about 49,000 people in the US, Argentina and Brazil, among other countries.;

    Hot Topics

    Related Articles